Results 171 to 180 of about 277,312 (326)

Allergic conjunctivitis.

Asian Pacific journal of allergy and immunology, 2002
The purpose of this research is to study the clinical features and risk factors of various types of allergic conjunctivitis. Four hundred and forty-five patients with a history of itching, foreign body sensation, lacrimation and red eyes were examined, and a skin test was performed and assessed to grade the severity. The mean age of the subjects was 24.
P, Kosrirukvongs, N, Visitsunthorn, P, Vichyanond, C, Bunnag   +3 more
openaire   +1 more source

Clinical and Molecular Effect of the Anti–IL‐18 Antibody Aletekitug in Adults With Atopic Dermatitis

Allergy, Volume 81, Issue 2, Page 539-551, February 2026.
At Week 12, aletekitug was associated with a −68.3% percentage change from baseline in EASI score. Aletekitug improved the transcriptional profile of lesional skin towards that of non‐lesional skin at Week 4 and Week 12. Aletekitug was well‐tolerated; no serious adverse event or death occurred, and no patient withdrew due to an adverse event.
Joanne Ellis, Léa Fortunato, Hannah Wajdner, Ester Del Duca, Joanna Barnard, Joanna C. Betts, Swaroop Bose, John Browning, Núria Buil‐Bruna, Scott Van Buren, Eden David, Scott Dinehart, Puneet Dhawan, Yeriel Estrada, Parima Ghafoori, Kiranmai Gumireddy, Zhenghong Li, Wei Jing Loo, Fiona Lovegrove, Jenny Lowe, Lawrence Charles Parish, Will Powley, Naveen Prasad, Joel Correa Da Rosa, Marieta Ruseva, Neda Shokrian, Farhat Syed, Chun‐Hang Tang, Gabriel K. Wong, John B. Kelly, Nicolas Wisniacki, Iain Uings, Emma Guttman‐Yassky   +32 more
wiley   +1 more source

Real‐world evidence of tirbanibulin in the treatment of actinic keratosis in Germany – prospective, multicenter, non‐interventional KLIR study

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 2, Page 186-193, February 2026.
Summary Background Tirbanibulin is an approved topical treatment for actinic keratosis (AK). This non‐interventional study investigated effectiveness and safety of tirbanibulin for AK. Patients and Methods The prospective KLIR‐study was conducted at 58 German dermatology centers (02/2022–09/2023).
Markus V. Heppt, Ina Hadshiew, Afra Kempf, Antje Melzer, Carola Berking   +4 more
wiley   +1 more source

AN EFFICACY COMPARISON STUDY BETWEEN TOPICAL ANTI ALLERGIC DRUGS IN PATIENTS WITH ALLERGIC CONJUNCTIVITIS IN WESTERN RAJASTHAN

, 2020
Pushpendra Chotiya, Arvind Chauhan
openalex   +1 more source

Activated T cells in an animal model of allergic conjunctivitis. [PDF]

, 1993
Isabel Carreras, B Carreras, Lindsay E. V. McGrath, Alison Rice, D L Easty   +4 more
openalex   +1 more source

PAE2 THE BURDEN OF ALLERGIC CONJUNCTIVITIS IN THE UK: FINDINGS FROM A RETROSPECTIVE REVIEW OF THE GPRD DATABASE 1990-2000

, 2003
AF Smith, Carlos P. Dotres Martínez, A Rubino, AJ BRON, AD Pitt   +4 more
openalex   +1 more source

Patch Testing Under Biologics: Six Cases From a Tertiary Centre

Contact Dermatitis, Volume 94, Issue 3, Page 299-301, March 2026.
Alessandra Chiei‐Gallo, Francesca Barei, Angelo V. Marzano, Silvia M. Ferrucci   +3 more
wiley   +1 more source

Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study

International Journal of Dermatology, Volume 65, Issue 2, Page 299-306, February 2026.
ABSTRACT Background Conjunctivitis is among the most frequent adverse events (AEs) emerged in clinical trials for all biologic drugs approved for atopic dermatitis (AD). However, real‐world comparative data on the incidence, risk factors, and management of conjunctivitis remain limited.
Luca Potestio, Cataldo Patruno, Marika Del Gaudio, Michela Ortoncelli, Simone Ribero, Francesca Barei, Silvia Mariel Ferrucci, Laura Bonzano, Ilaria Trave, Mario Bruno Guanti, Carlotta Gurioli, Bianca Maria Piraccini, Niccolò Gori, Elena Ippoliti, Ketty Peris, Laura Grigolato, Mariateresa Rossi, Caterina Foti, Paolo Romita, Benedetta Tirone, Eustachio Nettis, Maria Esposito, Maria Concetta Fargnoli, Lina Maria Magnanimi, Elena Pezzolo, Katharina Hansel, Luca Stingeni, Rosanna Satta, Maria Mariano, Flavia Pigliacelli, Flavia Manzo Margiotta, Marco Romanelli, Ruggero Cascio Ingurgio, Antonio Costanzo, Alessandra Narcisi, Monica Corazza, Emiliano Antiga, Pietro Morrone, Pietro Rubegni, Laura Calabrese, Laura Lazzeri, Giovanni Rubegni, Fabrizio Guarneri, Nicola Zerbinati, Andrea Carugno, Rosa Valentina Puca, Oriele Sarno, Claudio Marasca, Emanuela Martina, Francesca di Vico, Maddalena Napolitano   +50 more
wiley   +1 more source

Efficacy of Levocabastine Hydrochloride Ophthalmic Suspension in the Conjunctival Allergen Challenge Test in Japanese Subjects with Seasonal Allergic Conjunctivitis

, 2006
Etsuko Takamura, Keiko Nomura, Hiroshi Fujishima, Kazumi Fukagawa, Yoshiyuki Satake, Yuka Fukada, Mitsuru Sawa, Eiji Uchida   +7 more
openalex   +1 more source

Prevalence of Group A Streptococcal Pharyngitis and Antibiotic Susceptibility in Paediatric Patients With Sore Throats in Gaborone, Botswana

Tropical Medicine &International Health, Volume 31, Issue 2, Page 176-180, February 2026.
ABSTRACT Background Group A β‐haemolytic Streptococcus, also known as Streptococcus pyogenes, commonly causes childhood pharyngitis and can lead to severe complications like acute rheumatic fever and rheumatic heart disease. Timely penicillin treatment is vital in preventing these issues.
Julius Chacha Mwita, Souda Sajini, Kélin Engel, Tichaona Bernard Machiya, Mark E. Engel   +4 more
wiley   +1 more source